Patents by Inventor Shengxue Liu

Shengxue Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12134603
    Abstract: The present application relates to a synthesis method for N-methyl-3-substituted methyl-4-pyrazolamide derivative and N-methyl-3-substituted methyl-4-pyrazolic acid, including the following steps: step S1: synthesis of intermediate E; step S2: synthesis of intermediate D; step S3: synthesis of intermediate C; step S4: synthesis of N-methyl-3-substituted methyl-4-pyrazolamide derivative; and synthesis of N-methyl-3-substituted methyl-4-pyrazolic acid by decomposition of N-methyl-3-substituted methyl-4-pyrazolamide derivative.
    Type: Grant
    Filed: August 16, 2023
    Date of Patent: November 5, 2024
    Assignee: Shaoxing Shangyu Xin Yinbang Biochemical Co., Ltd.
    Inventors: Shengxue Liu, Yintao Shi, Qiang Gong, Sufang Zhong, Jianjiang Zhang, Xiaoyuan Qian, Fang Guo, Rujun Chen, Xiaoying Jian
  • Publication number: 20240083852
    Abstract: The present application relates to a synthesis method for N-methyl-3-substituted methyl-4-pyrazolamide derivative and N-methyl-3-substituted methyl-4-pyrazolic acid, including the following steps: step S1: synthesis of intermediate E; step S2: synthesis of intermediate D; step S3: synthesis of intermediate C; step S4: synthesis of N-methyl-3-substituted methyl-4-pyrazolamide derivative; and synthesis of N-methyl-3- substituted methyl-4-pyrazolic acid by decomposition of N-methyl-3-substituted methyl-4-pyrazolamide derivative.
    Type: Application
    Filed: August 16, 2023
    Publication date: March 14, 2024
    Inventors: Shengxue LIU, Yintao SHI, Qiang GONG, Sufang ZHONG, Jianjiang ZHANG, Xiaoyuan QIAN, Fang GUO, Rujun CHEN, Xiaoying JIAN
  • Publication number: 20200239842
    Abstract: Preparation and expansion methods for human pluripotent stem cell-derived human retinal pigment epithelial cells are provided. The preparation method includes the following steps: collecting 3D-PRE spheroids derived from human pluripotent stem cells, performing mechanical separation to remove non-RPE cells and clusters which are non-pigmented and retain a pigmented RPE cell sheet, enzymatically digesting the pigmented RPE cell sheet to obtain an RPE single cell suspension, and thereby the human pluripotent stem cell-derived human retinal pigment epithelial cells are obtained. The expansion method includes centrifuging the RPE single cell suspension and removing a supernatant, resuspending in an RPE cell medium and seeding into a cell culture container precoated with extracellular matrix to allow primary culture, and subculturing the cells after cells spread out.
    Type: Application
    Filed: April 28, 2018
    Publication date: July 30, 2020
    Applicant: ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY
    Inventors: Xiufeng ZHONG, Jian GE, Shengxu LIU, Fuhua PENG
  • Patent number: 9809827
    Abstract: The present invention provides a method of producing transgenic plants which are drought resistant, plants obtainable by the method and uses thereof.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: November 7, 2017
    Assignee: Institute of Botany, The Chinese Academy of Sciences
    Inventors: Feng Qin, Shengxue Liu, Xianglan Wang, Hongwei Wang
  • Publication number: 20160160230
    Abstract: The present invention provides a method of producing transgenic plants which are drought resistant, plants obtainable by the method and uses thereof.
    Type: Application
    Filed: July 18, 2014
    Publication date: June 9, 2016
    Inventors: Feng Qin, Shengxue Liu, Xianglan Wang, Hongwei Wang